- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06010498
The Effect of Eye Mask Applied on Patients Undergoing Coronary Artery Bypass Graft Surgery
The Effect of Eye Mask Applied on Patients Undergoing Coronary Artery Bypass Graft Surgery on Sleep Quality and Pain: Double-Blind Randomized Controlled Study
Introduction: Coronary Artery Bypass Graft (CABG) performed with open heart surgery technique is a successful operation in the treatment of cardiovascular diseases. Incision of the sternum region, saphenous vein graft, sternal retraction, presence of chest and mediastinal tubes cause pain. The pain experienced by the patients, the complications related to the disease they have, and the stress they experience cause an increase in sleep problems. In addition, the increase in sympathetic activity after surgery and nursing care interventions also affect sleep quality. The literature reports that sleep disorders affect the working physiology of the heart in patients with cardiac disease, adversely affect heart health and affect postoperative recovery. In addition, since sleep disorders are also associated with cardiovascular diseases, it is of great importance to improve the sleep quality of this group of patients. One of the non-pharmacological nursing interventions is the eye patch. The eye patch is an instrument made of fabric, with an elastic strap, aimed at pure darkness by diverting all light from the patient's eyes. The main physiological purpose of using an eye patch is to adjust the hormones melatonin and cortisol, which affect the circadian rhythm. As a result, it is thought that the eye patch will prevent patients from being exposed to excessive light in the hospital environment, the regulation of hormones and sleep quality will improve, and the pain will decrease.
Purpose: The aim of this study is to examine the effect of eye patch applied to patients undergoing coronary artery bypass graft surgery on sleep quality and pain.
Method: Individuals who have undergone coronary artery bypass graft surgery in accordance with the sampling inclusion criteria will be randomly assigned to the experimental and control groups by block randomization. After determining the groups, each patient in the experimental and control groups, whose written consent was obtained, will have the first researcher fill out the Descriptive Characteristics Form, Richards-Campbell Sleep Questionnaire and Numerical Pain Scale on the morning of the first night they spent in the clinic.
Patients in the experimental group will be given the "standard care" and "eye patch" application in the clinic on their 2nd and 3rd nights in the clinic. The patients in the control group will only be provided with the "standard care" in the clinic on their 2nd and 3rd nights in the clinic. Patients in both groups will be asked to fill out the Richards-Campbell Sleep Questionnaire and Numerical Pain Scale forms in the mornings of the 2nd and 3rd nights.
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kütahya, Turkey, 43000
- Necibe
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Over 18 years old
- Those under 65 (Studies show that nighttime awakenings and sleep durations change with age (Lie et al., 2018)
- Can speak Turkish
- Those who agreed to participate in the study
- Those who have not had open heart surgery before
- No emergency bypass surgery
- No intra-aortic balloon pump or pacemaker
- Not taking inotropic drugs
- Those who have not consumed coffee or hypnotic drugs at least 12 hours before
- Those who have not been working the night shift for the last 3 months
- No history of chronic pain (eg arthritis)
- Able to wear an eye mask on their own
- Not addicted to alcohol and drugs
- Does not have a psychological problem (such as depression, anxiety disorder)
- No anxiolytic use
- No chronic sleep problems
- Not using sleeping pills
Exclusion Criteria:
- Low risk factor for complications (eg ejection fraction < 35%).
- During CABG surgery, mitral valve repair or replacement (Each type of heart surgery will differ in terms of operation time, site of surgery, recovery time, and length of hospital stay, which may affect the patient's anxiety.)
- Patients with chest tube and drain
- Patients with vision problems
- Patients with hearing problems
- Patients with claustrophobia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Eye Mask Group
|
Control group (n)
|
|
No Intervention: Standart Care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
sleep quality measurement (Richards- Campbell Sleep Questionnaire)
Time Frame: Once a day on the second day in the morning, on the third day in the morning, on the fourth day in the morning
|
Richards- Campbell Sleep Questionnaire: Developed by Richards in 1987, the Richard-Campbell Sleep Questionnaire (RCSQ) is a 6-item scale that evaluates the depth of night sleep, the time it takes to fall asleep, the frequency of waking up, the time to stay awake when awakened, the quality of sleep, and the noise level in the environment.
Each item is evaluated on a chart between 0 and 100 with the visual analog scale technique.
A score of "0-25" from the scale indicates very bad sleep, and a score of "76-100" indicates very good sleep.
As the score of the scale increases, the sleep quality of the patients also increases.
The Cronbach α value of the scale developed by Richards was found to be 0.82.
The Turkish validity and reliability of the scale was investigated by Özlü and Özer in 2015 and the Cronbach α value was found to be 0.91.
|
Once a day on the second day in the morning, on the third day in the morning, on the fourth day in the morning
|
|
pain measurement (numerical pain scale)
Time Frame: Once a day on the second day in the morning, on the third day in the morning, on the fourth day in the morning
|
Numerical Pain Scale:It is based on the expression of pain intensity in numbers.
While the absence of pain is expressed as 0 in numerical scales, the number shown increases as the severity of pain increases, and 10 points represent unbearable pain.
Numerical scales have been adopted more because they facilitate the definition of pain severity and facilitate scoring and recording.
|
Once a day on the second day in the morning, on the third day in the morning, on the fourth day in the morning
|
Collaborators and Investigators
Investigators
- Principal Investigator: Burcu NAL, Msc RN, Kütahya Health Sciences University
- Principal Investigator: Gülşah GÜROL ARSLAN, Msc RN, Dokuz Eylul University
- Principal Investigator: Mehmet Ali ASTARCIOĞLU, Doctor, Kütahya Health Sciences University
- Principal Investigator: Ali İhsan PARLAR, Doctor, Kütahya Health Sciences University
- Principal Investigator: Necibe DAĞCAN, Msc RN, Dokuz Eylul University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Pathologic Processes
- Myocardial Ischemia
- Heart Diseases
- Cardiovascular Diseases
- Vascular Diseases
- Nervous System Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Postoperative Complications
- Pain
- Neurologic Manifestations
- Coronary Disease
- Coronary Artery Disease
- Pain, Postoperative
- Sleep Wake Disorders
Other Study ID Numbers
- KutahyaHSU-NECIBE-DAGCAN-0002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Shunmei MedicalNot yet recruitingCalcified Coronary Artery Disease | Coronary Arterial DiseasePoland, France, Spain
-
OPCI Core Laboratories LLCNot yet recruitingCoronary Artery Disease (CAD) | Coronary Calcification | Coronary Calcified Disease | Coronary Calcified NodulesUnited States
Clinical Trials on eye mask
-
Necmettin Erbakan UniversityNot yet recruitingCardiovascular Surgical ProceduresTurkey
-
Assiut UniversityUnknown
-
Hamideh SabbaghiNot yet recruitingDry Eye DiseaseIran, Islamic Republic of
-
Sakarya UniversityEnrolling by invitation
-
Peking University People's HospitalRecruiting
-
Singapore National Eye CentreNgee Ann Polytechnic SingaporeCompleted
-
He Eye HospitalNot yet recruitingEvaporative Dry EyeChina
-
Assiut UniversityCompleted
-
Istanbul University - CerrahpasaProf. Dr. Cemil Tascıoglu City HospitalRecruitingCoronary Artery Disease | Postoperative Pain | CABG | Postoperative Anxiety | Physiological ParameterTurkey
-
Ataturk UniversityCompletedSleep Disturbance | Intensive Care Unit Patients | Circadian Rhythm Sleep DisordersTurkey (Türkiye)